Agency for International Development – Federal Register Recent Federal Regulation Documents
Results 201 - 250 of 543
Office of Inspector General; Senior Executive Services (SES) Performance Review Board: Update
This notice is hereby given of the appointment of members of the updated U.S. Agency for International Development, Office of Inspector General's Senior Executive Service Performance Review Board.
Federal Policy for the Protection of Human Subjects
The Department of Health and Human Services and the other Federal Departments and Agencies listed in this document are extending the comment period on the Federal Policy for the Protection of Human Subjects notice of proposed rulemaking. The NPRM requests comment on proposed revisions to modernize, strengthen, and make more effective the Federal Policy for the Protection of Human Subjects that was promulgated as a Common Rule in 1991. The NPRM was published in the Federal Register on September 8, 2015.
Notice of December 1, 2015 President's Global Development Council Meeting
The President's Council on Global Development will meet on December 1, 2015 in Washington, DC at 12:15 p.m. Eastern Time. The meeting will be open to the public via live webcast. Details for the webcast can be found at https://www.whitehouse.gov/administration/ advisory-boards/global-development-council. The purpose of this meeting is to solicit public input on key global development issues. The President's Global Development Council will focus the discussion on issues of financial inclusion.
Various Administrative Changes and Clauses to the USAID Acquisition Regulation
The U.S. Agency for International Development (USAID) seeks public comment on a proposed rule that would revise the Agency for International Development Acquisition Regulation (AIDAR) to maintain consistency with Federal and Agency regulations and incorporate current and new USAID clauses into the regulation.
Notice of Advisory Committee on Voluntary Foreign Aid Meeting
Pursuant to the Federal Advisory Committee Act, notice is hereby given of a meeting of the Advisory Committee on Voluntary Foreign Aid (ACVFA).
USAID Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards
USAID is issuing a final rule adopting with amendments the ``Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards,'' issued by the Office of Management and Budget and published in Federal Register on December 26, 2013. Consistent with the OMB rule, USAID's rule supersedes USAID's ``Administration of Assistance Awards to U.S. Non-Governmental Organizations.'' Parts of this final rule apply to for-profit entities in limited circumstances and to foreign organizations as described in this guidance.
Schedules of Controlled Substances: Removal of [123
With the issuance of this final rule, the Administrator of the Drug Enforcement Administration removes [\123\I]ioflupane from the schedules of the Controlled Substances Act. This action is pursuant to the Controlled Substances Act which requires that such actions be made on the record after an opportunity for a hearing through formal rulemaking. Prior to the effective date of this rule, [\123\I]ioflupane was, by definition, a schedule II controlled substance because it is derived from cocaine via ecgonine, both of which are schedule II controlled substances. This action removes the regulatory controls and administrative, civil, and criminal sanctions applicable to controlled substances, including those specific to schedule II controlled substances, on persons who handle (manufacture, distribute, reverse distribute, dispense, conduct research, import, export, or conduct chemical analysis) or propose to handle [\123\I]ioflupane.
Manufacturer of Controlled Substances Registration: PCAS-Nanosyn, LLC
PCAS-Nanosyn, LLC applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants PCAS-Nanosyn, LLC registration as a manufacturer of those controlled substances.
Manufacturer of Controlled Substances Registration: Johnson Matthey Pharmaceutical Materials, Inc.
Johnson Matthey Pharmaceutical Materials, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Johnson Matthey Pharmaceutical Materials, Inc. registration as a manufacturer of those controlled substances.
Schedules of Controlled Substances: Placement of Eluxadoline Into Schedule IV
The Drug Enforcement Administration proposes to place the substance eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6- dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2- yl)ethyl]amino]methyl]-2-methoxybenzoic acid), including its salts, isomers, and salts of isomers, into schedule IV of the Controlled Substances Act (CSA). This proposed scheduling action is pursuant to the CSA which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule IV controlled substances on persons who handle (manufacture, distribute, dispense, import, export, engage in research, conduct instructional activities, or possess), or propose to handle eluxadoline.
Manufacturer of Controlled Substances Registration: Patheon Pharmaceuticals, Inc.
Patheon Pharmaceuticals, Inc. applied to be registered as a manufacturer of a certain basic class of controlled substance. The Drug Enforcement Administration (DEA) grants Patheon Pharmaceuticals, Inc. registration as a manufacturer of this controlled substance.
Manufacturer of Controlled Substances Registration: National Center for Natural Products Research (NIDA MPROJECT), Inc.
National Center for Natural Products Research (NIDA MPROJECT), Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants National Center for Natural Products Research (NIDA MPROJECT), Inc. registration as a manufacturer of those controlled substances.
Manufacturer of Controlled Substances Registration: Cody Laboratories, Inc.
Cody Laboratories, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Cody Laboratories, Inc. registration as a manufacturer of those controlled substances.
Manufacturer of Controlled Substances Registration: Sigma Aldrich Research Biochemicals, Inc.
Sigma Aldrich Research Biochemicals, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Sigma Aldrich Research Biochemicals, Inc. registration as a manufacturer of those controlled substances.
Importer of Controlled Substances Registration: Meridian Medical Technologies
Meridian Medical Technologies applied to be registered as an importer of a certain basic class of controlled substance. The Drug Enforcement Administration (DEA) grants Meridian Medical Technologies registration as an importer of this controlled substance.
Manufacturer of Controlled Substances Registration: Cayman Chemicals Company
Cayman Chemicals Company applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Cayman Chemicals Company registration as a manufacturer of those controlled substances.
Importer of Controlled Substances Registration: Actavis Laboratories FL, Inc.
Actavis Laboratories FL, Inc. applied to be registered as an importer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Actavis Laboratories FL, Inc., registration as an importer of those controlled substances.
Importer of Controlled Substances Registration: Sigma-Aldrich International GMBH, Sigma Aldrich Co., LLC
Sigma-Aldrich International GMBH, Sigma Aldrich Co., LLC applied to be registered as an importer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Sigma-Aldrich International GMBH, Sigma Aldrich Co., LLC registration as an importer of those controlled substances.
Manufacturer of Controlled Substances Registration: Cambrex Charles City
Cambrex Charles City applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Cambrex Charles City registration as a manufacturer of those controlled substances.
Importer of Controlled Substances Registration: Almac Clinical Services Inc. (ACSI)
Almac Clinical Services Inc. (ACSI) applied to be registered as an importer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Almac Clinical Services Inc. (ACSI) registration as an importer of those controlled substances.
Importer of Controlled Substances Registration: Johnson Matthey, Inc.
Johnson Matthey, Inc. applied to be registered as an importer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Johnson Matthey, Inc., registration as an importer of those controlled substances.
Importer of Controlled Substances Registration: Hospira
Hospira applied to be registered as an importer of certain basic class of controlled substances. The Drug Enforcement Administration (DEA) grants Hospira registration as an importer of this controlled substance.
Manufacturer of Controlled Substances Registration: Johnson Matthey, Inc.
Johnson Matthey, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Johnson Matthey, Inc. registration as a manufacturer of those controlled substances.
Manufacturer of Controlled Substances Registration: Pharmacore, Inc.
Pharmacore, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Pharmacore, Inc. registration as a manufacturer of those controlled substances.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.